Sign In
Buy EVGN
$0.471
-0.0184 (-3.76%)
At Close: Jul 31, 2026
Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today that it has entered a
Hedge Funds Have Never Been More Bullish On Evogene Ltd. (EVGN)
11:57pm, Sunday, 22'nd Dec 2019
Is Evogene Ltd. (NASDAQ:EVGN) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have num
The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
12:00am, Friday, 06'th Dec 2019Lavie Bio Announces Advancement in Its Product Development Pipeline for Wheat Bio-stimulants
12:00pm, Monday, 18'th Nov 2019
Leading wheat bio-stimulant candidate for spring wheat, exhibiting consistent performance, advancing to 'development stage 2', in line with Lavie Bio's commercialization plans for 2022 REHOVOT, Israel
Evogene Reports Third Quarter 2019 Financial Results
12:00pm, Wednesday, 13'th Nov 2019
Conference call and webcast: November 13th, 9:00 am ET REHOVOT, Israel , Nov. 13, 2019 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel produ
Evogene Q3 EPS $(0.16) Up From $(0.19) YoY, Sales $97K Do Not Compare To $1.9M Estimate
12:00am, Wednesday, 13'th Nov 2019Biomica Reports Positive Preliminary Results in Animal Studies in Its Immuno-oncology Program
12:00pm, Tuesday, 12'th Nov 2019
Demonstrating Improved Anti-Tumor Activity Following Treatment with BMC 121 & BMC 127 REHOVOT, Israel , Nov. 12, 2019 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovat
REHOVOT, Israel, Nov. 6, 2019 /PRNewswire/ -- Canonic, a wholly owned subsidiary of Evogene Ltd. (EVGN) (EVGN.TA) focused on the development of medical cannabis products, announces today the initiati
Evogene Reports Its Canonic Wholly-Owned Subsidiary Initiates Cultivation, Breeding Program Of Cannabis Varieties
12:00am, Wednesday, 06'th Nov 2019Evogene Financial Results for the Third Quarter of 2019 Earnings Announcement Schedule
11:00am, Wednesday, 23'rd Oct 2019
REHOVOT, Israel , Oct. 23, 2019 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it w
Biomica Reports Will Collaborate With Weizmann Institute To Develop Selective Treatment Against Antibiotic Resistant Bacteria
12:00am, Wednesday, 23'rd Oct 2019Biomica Announces Advancement to Pre-Clinical Studies in its Inflammatory Bowel Disease Program
11:00am, Wednesday, 02'nd Oct 2019
REHOVOT, Israel, Oct. 2, 2019 /PRNewswire/ -- Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (EVGN) and (EVGN.TA
Lavie Bio, Evogene's Ag-Biologicals Subsidiary, Announces the Nomination of Industry Experts to its Board of Directors
11:00am, Wednesday, 11'th Sep 2019
The nomination of industry experts is expected to support the company's management in execution of its product development and commercialization roadmap REHOVOT, Israel , Sept. 11, 2019 /PRNewswire/ -
